Latest filing published 22 Mar 2024 for GSK plc, €8,443.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Urs Rohner: trading record in brief
All filings by Urs Rohner on record concern GSK plc. Over a trading history stretching from 21 June 2023 to 20 March 2024, the count stands at 4 filings.
On the market, this insider has only ever bought: 4 purchases, €33k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2024 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €8,036. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 22 March 2024, the filings show an open-market purchase worth €8,443 in GSK plc. Filings reach the RNS (LSE) feed a median of 2 days after the trade. The regulation allows three business days to notify a trade (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Urs Rohner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 434 shares@ £16.61626.0% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:5116598-1Canonical exit: 18 Jun 2024 (T+90)
- 478 shares@ £14.49624.7% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:5012405-2Canonical exit: 19 Mar 2024 (T+90)
- 453 shares@ £15.28824.6% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4907954-1Canonical exit: 19 Dec 2023 (T+90)
- 506 shares@ £13.678424.7% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4813178-0Canonical exit: 19 Sept 2023 (T+90)
4 of 4 declarations
